BIOMAT Database Logo BIOMAT Database Logo

Binding of [3H]apomorphine to striatal membranes prepared from rat brain after 6-hydroxydopamine and kainic acid lesions. 1980

N Fujita, and K Saito, and K Iwatsubo, and A Hirata, and Y Noguchi, and H Yoshida

UI MeSH Term Description Entries
D007608 Kainic Acid (2S-(2 alpha,3 beta,4 beta))-2-Carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid. Ascaricide obtained from the red alga Digenea simplex. It is a potent excitatory amino acid agonist at some types of excitatory amino acid receptors and has been used to discriminate among receptor types. Like many excitatory amino acid agonists it can cause neurotoxicity and has been used experimentally for that purpose. Digenic Acid,Kainate,Acid, Digenic,Acid, Kainic
D008297 Male Males
D011759 Pyrrolidines Compounds also known as tetrahydropyridines with general molecular formula (CH2)4NH. Tetrahydropyridine,Tetrahydropyridines
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D006892 Hydroxydopamines Dopamines with a hydroxy group substituted in one or more positions. Hydroxydopamine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001058 Apomorphine A derivative of morphine that is a dopamine D2 agonist. It is a powerful emetic and has been used for that effect in acute poisoning. It has also been used in the diagnosis and treatment of parkinsonism, but its adverse effects limit its use. Apokinon,Apomorphin-Teclapharm,Apomorphine Chloride,Apomorphine Hydrochloride,Apomorphine Hydrochloride Anhydrous,Apomorphine Hydrochloride, Anhydrous,Apomorphine Hydrochloride, Hemihydrate,Britaject,Apomorphin Teclapharm
D013570 Synaptic Membranes Cell membranes associated with synapses. Both presynaptic and postsynaptic membranes are included along with their integral or tightly associated specializations for the release or reception of transmitters. Membrane, Synaptic,Membranes, Synaptic,Synaptic Membrane
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

N Fujita, and K Saito, and K Iwatsubo, and A Hirata, and Y Noguchi, and H Yoshida
Evidence for interactions between [3H]glutamate and [3H]kainic acid binding sites in rat striatal membranes. Possible relevance for kainic acid neurotoxicity.
March 1983, Neuroscience letters,
N Fujita, and K Saito, and K Iwatsubo, and A Hirata, and Y Noguchi, and H Yoshida
The effects of kainic acid and 6-hydroxydopamine lesions, metal ions and GTP on in vitro binding of the D-2 dopamine agonist, [3H]N-0437, to striatal membranes.
November 1987, European journal of pharmacology,
N Fujita, and K Saito, and K Iwatsubo, and A Hirata, and Y Noguchi, and H Yoshida
Reversible decrease in dopaminergic 3H-agonist binding after 6-hydroxydopamine and irreversible decrease after kainic acid.
January 1983, Life sciences,
N Fujita, and K Saito, and K Iwatsubo, and A Hirata, and Y Noguchi, and H Yoshida
Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding.
June 1979, European journal of pharmacology,
N Fujita, and K Saito, and K Iwatsubo, and A Hirata, and Y Noguchi, and H Yoshida
Kainic acid binding to membranes of striatal neurons.
January 1979, Life sciences,
N Fujita, and K Saito, and K Iwatsubo, and A Hirata, and Y Noguchi, and H Yoshida
Binding of [3H] kainic acid, and analogue of Lglutamate, to brain membranes.
January 1976, Journal of neurochemistry,
N Fujita, and K Saito, and K Iwatsubo, and A Hirata, and Y Noguchi, and H Yoshida
Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
January 1981, Journal of neurochemistry,
N Fujita, and K Saito, and K Iwatsubo, and A Hirata, and Y Noguchi, and H Yoshida
[Analysis of 3H-kainic acid binding to brain membranes in rats and frogs].
May 1985, Biulleten' eksperimental'noi biologii i meditsiny,
N Fujita, and K Saito, and K Iwatsubo, and A Hirata, and Y Noguchi, and H Yoshida
Effects of acromelic acid A on the binding of [3H]-kainic acid and [3H]-AMPA to rat brain synaptic plasma membranes.
January 1992, British journal of pharmacology,
N Fujita, and K Saito, and K Iwatsubo, and A Hirata, and Y Noguchi, and H Yoshida
Binding of [3H]ADTN to rat striatal membranes.
April 1982, Biochemical pharmacology,
Copied contents to your clipboard!